- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06289543
Preoperative Oral Carbohydrate on Gastric Emptying
The Effect of A Newly Formulated Preoperative Oral Carbohydrate Solution on Gastric Emptying, Postoperative Nausea and Vomiting and Stress Response
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The current preoperative fasting guidelines recommend, applying preoperative carbohydrate solution 2 hours before the operation to minimize prolonged fasting time potential negative effects and improve patient comfort. Fasting after midnight before the operation day is a widespread practice. The major obstacle to preoperative carbohydrate solutions becoming prevalent and extremely long fasting time is the limited product; which is proven safe and efficient, and unavailable in several countries. In this study, our objective is to analyze the gastric volume, preoperative anxiety, stress response, postoperative insulin resistance, and postoperative nausea and vomiting by utilizing a low osmolality oral carbohydrate solution prepared with ginger and melissa.
109 patients who underwent elective laparoscopic cholecystectomy, aged 18-65 years, and ASA physical state 1-2 were included in the study. The patients were divided into 3 groups: Group A, who would not eat anything 6-8 hours before the operation, Group S, who drank 400 ml of water 2 hours before the operation, and Group K, which drank 400 ml preoperative oral carbohydrate solution (PreOKH) 2 hours before the operation. Before induction of anesthesia (T1), patients' antral gastric cross-sectional area (GKA) and gastric volume (GV) were evaluated by gastric ultrasound. The preoperative anxiety level of the patients was determined by the State-Trait Anxiety Inventory (STAl) before the operation (T1), and the symptoms affecting the preoperative patient comfort parameters (thirst, hunger, dry mouth, fatigue) were measured 2 hours before the operation (T0) and before the induction (T1) evaluated with the visual analog scale (VAS). Postoperative nausea and vomiting (PONV) and postoperative pain levels were recorded. Blood glucose, insulin, and cortisol levels of the patients were measured 2 hours before the operation (T0), before induction (T1), and postoperative 2nd hour (T3)
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Emine Seyda Teloglu
- Phone Number: +905394191544
- Email: eteloglu@bezmialem.edu.tr
Study Locations
-
-
Fatih
-
Istanbul, Fatih, Turkey
- Recruiting
- Bezmialem University
-
Contact:
- Kazim Karaaslan
- Phone Number: +905055213865
- Email: kazimkaraslan@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Between the ages of 18-65
- Elective laparoscopic cholecystectomy planned under general anesthesia
- American Society of Anesthesiologists (ASA) class I-II physical condition
Exclusion Criteria:
Patients with gastroesophageal reflux and gastrointestinal motility disorders diabetes mellitus Mental retardation, previous neurological disease symptoms (syncope, dementia, Alzheimer, etc.) Chronic alcoholism Difficult Intubation Patients with ASA physical status classes ≥III Patients with a body mass index of 35 and above History of Meniere and motion sickness Presence of previous history of postoperative nausea and vomiting Smoking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Starvation
Fasting for 6-8 hours before the operation
|
|
|
Active Comparator: Water
drink 400ml of water 2 hours before the operation
|
water and solution will be given to patients to drink 2 hours before the operation
Other Names:
|
|
Active Comparator: oral carbohydrate
drink 400ml of solution 2 hours before the operation
|
water and solution will be given to patients to drink 2 hours before the operation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastric volume
Time Frame: prior to anesthesia induction
|
Assessment of gastric volume by ultrasound
|
prior to anesthesia induction
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
preoperative anxiety
Time Frame: before coming to the operating room, Scored between 20 and 80 points. A high score indicates high anxiety
|
preoperative anxiety will be assessed with the State-Trait Anxiety Inventory
|
before coming to the operating room, Scored between 20 and 80 points. A high score indicates high anxiety
|
|
postoperative nausea and vomiting
Time Frame: up to postoperative 24 hours, numeric rank score is scored between 0 and 3 points
|
postoperative nausea and vomiting scores of the patients will be evaluated
|
up to postoperative 24 hours, numeric rank score is scored between 0 and 3 points
|
|
thirst, hunger, fatigue, dry mouth
Time Frame: before drink (2 hous before surgery), prior to anesthesia induction, visual analog scale is scored between 0 and 10
|
thirst, hunger, fatigue, dry mouth will be evaluated with visual analog scale
|
before drink (2 hous before surgery), prior to anesthesia induction, visual analog scale is scored between 0 and 10
|
|
Postoperative Pain Score
Time Frame: up to postoperative 24 hours, visual analog scale is scored between 0 and 10
|
Postoperative Pain Score will be evaluated with visual analog scale
|
up to postoperative 24 hours, visual analog scale is scored between 0 and 10
|
|
postoperative insulin resistance
Time Frame: glucose, insulin and cortisol will be measured 2 hours before surgery(before drink), before induction and 2 hours postoperatively
|
Blood glucose mg/dL, Insulin milli-International unit/L, Cortisol µg/dL
|
glucose, insulin and cortisol will be measured 2 hours before surgery(before drink), before induction and 2 hours postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BVU-ESTELOGLU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.